CTCX

Carmell Corporation Class A · NASDAQ

Sector Health Technology
Industry Biotechnology
Website carmellrx.com
Employees(FY) 14
ISIN US1429221039

Performance

-5.96%

1W

-6.82%

1M

-43.99%

3M

-12.77%

6M

-46.19%

YTD

-79.92%

1Y

Profile

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of CTCX 2024-05-10

Overview:

In analyzing the technical indicators for CTCX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and recommendations for potential investors.

Trend Indi...

See more ...

Recent News & Updates

2024-05-15 20:54
CTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023(Investorplace)
2024-04-11 04:30
Carmell Announces Successful Closing of $3.0 Million Private Placement(Globenewswire)
2024-04-03 20:30
Carmell Announces $3.0 Million Private Placement(Globenewswire)
2024-03-26 21:15
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction(Globenewswire)
2024-03-20 04:39
Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary(Globenewswire)
2024-03-18 03:16
Carmell to Host Investor Webinar, Unveiling the Secretome: On the Eve of Product Launch Featuring Key Opinion Leaders in the Medical Aesthetics Field(Globenewswire)
2024-02-25 19:30
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024(Globenewswire)
2023-11-15 19:30
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors(Globenewswire)
2023-09-12 00:35
Moonshot Client Axolotl Announces Merger with Carmell Therapeutics, Elevating the Field of Regenerative Medicine(Yahoo Finance)
2023-09-05 06:03
Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics(Yahoo Finance)
2023-08-09 03:41
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity(Yahoo Finance)
2023-07-26 19:00
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company(Yahoo Finance)

Page 1 of 1

previousnext